To consolidate the relationship between GPAT3 overexpression/LD accumulation and chemoresistance/tumor immunosuppression, flow cytometry and HPLC–MS were performed on hepatic‐metastasis samples from CRC (CRC‐HM group) and control CRC (no recurrence/metastasis) patients. The gene discussed is GPAT3; the disease is colorectal carcinoma.